Changes To The NHS: How Can Pharma Best Position Itself?
Executive Summary
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.
You may also be interested in...
Spanish Pharma Industry Appeals Local Drug Funding Decisions
Spain's drug industry appeals against a court ruling allowing local drug funding decisions.
NICE Likely To Lose Cost-Watchdog Status By 2013
The U.K.'s National Institute for Clinical Excellence (NICE) will likely no longer have any role in drug cost-effectiveness decisions after 2013, according to officials.